Metropolitan Life Insurance Company (MetLife)’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,149
| Closed | -$29.5K | – | 1482 |
|
|
2024
Q1 | $29.5K | Hold |
2,149
| – | – | ﹤0.01% | 1669 |
|
|
2023
Q4 | $19.8K | Hold |
2,149
| – | – | ﹤0.01% | 1930 |
|
|
2023
Q3 | $13K | Hold |
2,149
| – | – | ﹤0.01% | 2097 |
|
|
2023
Q2 | $16.7K | Buy |
+2,149
| New | +$16.7K | ﹤0.01% | 2029 |
|
|
2022
Q1 | – | Sell |
-8,707
| Closed | -$128K | – | 2556 |
|
|
2021
Q4 | $128K | Buy |
8,707
+161
| +2% | +$2.37K | ﹤0.01% | 2331 |
|
|
2021
Q3 | $179K | Buy |
8,546
+1,254
| +17% | +$26.2K | ﹤0.01% | 2164 |
|
|
2021
Q2 | $129K | Buy |
7,292
+688
| +10% | +$12.2K | ﹤0.01% | 2453 |
|
|
2021
Q1 | $162K | Hold |
6,604
| – | – | ﹤0.01% | 2162 |
|
|
2020
Q4 | $224K | Buy |
+6,604
| New | +$224K | ﹤0.01% | 1866 |
|
|
2020
Q3 | – | Sell |
-3,187
| Closed | -$107K | – | 2585 |
|
|
2020
Q2 | $107K | Buy |
+3,187
| New | +$107K | ﹤0.01% | 2216 |
|